Keywords: Novartis, Ruvise, PAH, EMA, Bristol-Myers, BMS-986094, Settlement, Global Fund, German donation

News briefs: Novartis drops Ruvise MAA; B-MS settlement; Germany donates to Global Fund

Article | 25 January 2013

Print This

The European Medicines Agency says it has been formally notified by Swiss drug major Novartis (NOVN: VX) of its decision ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in